Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Frontier Ip Group Plc LSE:FIPP London Ordinary Share GB00B63PS212 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.50 -2.04% 72.00 39,232 15:40:40
Bid Price Offer Price High Price Low Price Open Price
70.00 74.00 73.50 68.50 73.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Nonequity Investment Instruments 0.36 10.24 17.47 4.1 37
Last Trade Time Trade Type Trade Size Trade Price Currency
15:40:35 O 4,225 71.00 GBX

Frontier Ip (FIPP) Latest News

More Frontier Ip News
Frontier Ip Investors    Frontier Ip Takeover Rumours

Frontier Ip (FIPP) Discussions and Chat

Frontier Ip Forums and Chat

Date Time Title Posts
18/6/202212:35Frontier IP277
30/7/201123:11Why have they bothered1

Add a New Thread

Frontier Ip (FIPP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:42:0271.004,2252,999.75O
14:41:5771.003,0002,130.00O
14:40:3671.003,0002,130.00O
14:04:0570.001,5001,050.00O
14:02:2872.007,5005,400.00O
View all Frontier Ip trades in real-time

Frontier Ip (FIPP) Top Chat Posts

DateSubject
01/7/2022
09:20
Frontier Ip Daily Update: Frontier Ip Group Plc is listed in the Nonequity Investment Instruments sector of the London Stock Exchange with ticker FIPP. The last closing price for Frontier Ip was 73.50p.
Frontier Ip Group Plc has a 4 week average price of 68.50p and a 12 week average price of 66p.
The 1 year high share price is 128.25p while the 1 year low share price is currently 66p.
There are currently 50,762,406 shares in issue and the average daily traded volume is 129,318 shares. The market capitalisation of Frontier Ip Group Plc is £36,548,932.32.
01/6/2022
08:48
aqc888: Good to see Frontier IP has leading technology in field work. One of many investments frontier have in remarkably relevant areas for todays changing world -which makes the recent share price decline all the more disconnected, especially since they have so much cash in the bank following the sale of exscentia. It appears x40 of the robots are already due to be dispatched to this one raspberry farm. https://www.theguardian.com/business/2022/jun/01/uk-raspberry-picking-robot-soft-fruit
18/3/2022
08:43
b3rt1e: petewy yesterday's half year results for FIPP ahead of managements and market expectations,· Pre-tax profits rose by 239 per cent to £10.3 million (31 December 2020: £3.0 million) · Unrealised profit on the revaluation of investments rose by 197 per cent to £11.9 million (31 December 2020: £4.0 million) · Fair value of portfolio rose by 37 per cent to £43.9 million at 31 December 2021 (30 June 2021: £32.0 million; 31 December 2020: £23.4 million) · Basic earnings per share increased by 162 per cent. to 14.54p (31 December 2020: 5.56p) · Net assets per share increased to 84.7p as at 31 December 2021 (30 June 2021: 69.8p; 31 December 2020: 56.8p) · Post period end, the Group realised approximately £6.1 million through the sale of 25% of its holding in Exscientia As I said yesterday, would be good to know what the Brokers are now forecasting as I believe it was north of 120p fair value before these numbers.
17/2/2022
18:09
km18: ...from last year... Company overview: Frontier IP is a company focused on commercialisation of intellectual property. They build value for their clients proactively through technology validation, early industry engagement and fund raising. The company has an established portfolio of clients and works with universities as sources of IP and deal flow. They also build a network of sources of capital for the client and aim for earning equity in return for strategic and commercial support. It is a very interesting business model, that is clearly working well. Growth is organic, supported by the absence of acquisitions over the past 10 years. Financials look promising to say the least. Revenue CAGR is of 32%, which on net profit level is transformed in 45%. ROCE is standing at 16.3% on a trailing twelve-month basis and is in the top quartile of the industry. Last but not least, the gearing is negative, as the company is debt free. Today, they have released the annual results for the period ending in June 2021. FV of portfolio swelled by 64% to $31.19 and PBT is 145% ahead of 2020 figures at £10.24m. Basic EPS are also significantly above previous figures at 17.47p. The Groups is also noting that many of the companies in their portfolio are “reaching inflection points”, characterized by strengthening of management teams, increased pace of funding rounds and industry engagement....from WealthOracleAM https://wealthoracle.co.uk/detailed-result-full/FIPP/223
14/2/2022
14:22
swiss paul: 14 February 2022 Frontier IP Group plc ("Frontier IP" or the "Group") Sale of shares in Exscientia Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that further to the announcement released by the Group on 25 January 2022, the Group has sold a further 207,299 American Depositary Shares ("ADSs") of portfolio company Exscientia plc ("Exscientia") (Nasdaq: EXAI) for net proceeds of approximately $4.3 million (approximately £3.2 million) at an average price of $20.63 per ADS (the "Exscientia Share Sales"). The Exscientia Share Sales took place between 1 February 2022 and 11 February 2022. The book value of the ADSs sold as at 30 June 2021, being the last published balance sheet of the Group, was £1.75 million and the Exscientia Share Sales have generated an estimated realised gain of £1.41 million for Frontier IP in the current financial year to 30 June 2022. Following the Exscientia Share Sales, Frontier IP will be interested in 1,173,600 shares in Exscientia. The Directors of Frontier IP intend to use the net proceeds from the sale of ADSs in Exscientia for general working capital purposes and to provide further support to the Group's existing portfolio companies. In aggregate, the Group has sold a total of 391,200 Exscientia ADSs for net proceeds of approximately $8.3 million (approximately £6.1 million) generating an estimated realised gain of £2.79 million for Frontier IP in the current financial year to 30 June 2022. Exscientia uses artificial intelligence ("AI") to modernise the way new medicines are discovered and developed, aiming to deliver medicines faster than industry standards. Exscientia has built a complete end-to-end solution of AI and experimental technologies for target identification, drug candidate design, translational models and patient selection. ADSs of Exscientia trade on the Nasdaq Global Select Market. Each ADS represents one ordinary share in Exscientia. On 7 January 2022, Exscientia announced a strategic research collaboration with Sanofi that will entitle Exscientia to an upfront cash payment of $100 million with the potential for $5.2 billion in total milestones plus tiered royalties. Exscientia announced its third quarter results to 30 September 2021 on 17 November 2021. These showed that based on unaudited financials for the nine months ended 30 September 2021, Exscientia generated revenue of £23.2 million and a loss before taxation of £33.1 million.
25/1/2022
16:32
swiss paul: Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that further to the announcement released by the Group on 12 January 2022 the Group has sold a total of 183,901 American Depositary Shares ("ADSs") of portfolio company Exscientia plc ("Exscientia") (Nasdaq: EXAI) for net proceeds of approximately $4.0 million (approximately £2.9 million) at an average price of $21.68 per ADS (the "Exscientia Share Sales"). The Exscientia Share Sales took place between 10 January 2022 and 21 January 2022. The book value of the ADSs sold as at 30 June 2021, being the last published balance sheet of the Group, was £1.55 million and the Exscientia Share Sales have generated an estimated realised gain of £1.38 million for Frontier IP in the current financial year to 30 June 2022. Following the Exscientia Share Sales, Frontier IP will be interested in 1,380,899 shares in Exscientia. The Directors of Frontier IP intend to use the net proceeds from the sale of ADSs in Exscientia for general working capital purposes and to provide further support to the Group's existing portfolio companies.
12/1/2022
12:02
acuere: Starts to make sense now re Exscientia. “As at the date of this announcement a small portion has been sold in January 2022 and the Group will provide a further update at the appropriate time.” So no selling until this month. Exscientia floated beginning of October and was in high $20s for a while. I had hoped they would of sold some then but maybe they were tied in for 3 months. The further update when appropriate comment would suggest they will be selling more if not all at some stage. As we are not forced sellers I imagine they would want at least $22 (ipo price), so should only sell into share price strength. This will certainly give them a large cash pile to invest elsewhere or maintain % stake in some of the other rising stars. As I’ve said before, current share price looks very cheap for a company that’s already started to realise it’s potential.
12/1/2022
07:56
zipstuck: The exscientia share price was $26 at the end of June now $19 though.hxxps://www.hl.co.uk/shares/shares-search-results/e/exscientia-plc-ads-each-repr-1-ord-sh
07/1/2022
15:52
acuere: It at least needs Fipp to announce it, to give any real uplift. Problem is these sort of shares are out of favour at the moment and I think we have an overhang in the stock for now. My buy today was below mid and shows as a sell and i suspect it’s not the only one. It’s a great price to get in at for longtermers now but it might get cheaper short term.
07/1/2022
15:11
tizo100: I saw this announcement this morning would have thought there would have being an uplift in the share price.
02/10/2021
10:02
acuere: Daily Mail seems to be the only paper to have picked up on the value to Fipp of the Exscientia float. At closing share price the stake worth about £30m hTTps://www.dailymail.co.uk/money/markets/article-10050501/MARKET-REPORT-Darktrace-sees-share-price-dented.html
Frontier Ip share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
FIPP
Frontier I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 16:14:53